Artal Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-253,863
Closed -$20.8M 126
2024
Q1
$20.8M Buy
+253,863
New +$20.8M 0.53% 25
2023
Q2
Sell
-300,000
Closed -$5M 129
2023
Q1
$5M Buy
+300,000
New +$5M 0.3% 62
2020
Q1
Sell
-350,000
Closed -$2.81M 107
2019
Q4
$2.81M Hold
350,000
0.11% 76
2019
Q3
$2.41M Buy
350,000
+250,000
+250% +$1.72M 0.1% 80
2019
Q2
$830K Buy
+100,000
New +$830K 0.03% 88